Use of posteroventral pallidotomy for treatment of Parkinson's disease: Is pallidotomy still an experimental procedure? A review and commentary

Stereotactic and Functional Neurosurgery

Volumn 70, Issue 1, 1998, Pages 19-31

  Jacques, D S ^a   Eagle, K S ^a   Kopyov, O V ^a  

^a GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

Basal ganglia; Experimental; Globus pallidus; Pallidotomy; Parkinson's disease

Indexed keywords

ADULT; AGED; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NERVE TRACT; NEUROANATOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIDOTOMY; PARKINSON DISEASE; REVIEW;

EID: 0031682068     PISSN: 10116125     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029594     Document Type: Review

References (95)

1. Parkinson J:An Essay on the Shaking Palsy. London, Sherwood, Neely & Jones, 1817.
2. Tretiakoff CC:Contribution à l'étude de l'anatomie pathologique du locus niger de Soemmering avec quelques déductions relatives à la pathogénie des troubles du tonus musculaire de la maladie de Parkinson; thèse Paris, 1919.
3. Hassler R:Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychiatr Neurol 1938;48:387-476.
4. Barbeau A:Parkinson's disease and its treatment. Neurol Neurosurg 1979;1:1-8.
5. Kish SJ, Rajput A, Gilbert J, Rozdilsky B, Chang LJ, Shannak K, Hornykiewicz O:Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease:correlation with striatal dopamine loss. Ann Neurol 1986;20:26-31.
6. Cotzias GC, Van Woert MH, Schiffer LM:Aromatic amino acids and modification of Parkinsonism. N Engl J Med 1967;276:374-379.
7. Fahn S:Adverse effects of levodopa; in Olanow CW, Lieberman A (eds):Scientific Basis for Therapy in Parkinson's Disease. New York, Parthenon Press, 1992.
8. Cederbaum JM, Olanow CW:Aspects of levodopa pharmacokinetics and pharmacodynamics:Bases of the modifcation of drug response during chronic treatment of Parkinson's disease; in Olanow CW, Lieberman A (eds):Scientific Basis for Therapy in Parkinson's Disease. New York, Parthenon Press, 1992.
9. Talaraich J, Paillas JE, David M:Dyskinésie de type hémiballique traitée par cortectomie frontale limitée, puis par coagulation de l'anse lenticulaire et de la portion interne du globus pallidus. Amélioration importante depuis un an. Rev Neurol 1950;83:440-451.
10. Narabayashi H, Okuma T:Procaine-oil blocking of the globus pallidus for the treatment of rigidity and tremor of parkinsonism. Proc Jpn Acad 1953;29:134-137.
11. Svennilson E, Torvik A, Lowe R, Leksell L:Treatment of parkinsonism by stereotactic thermolesions in the pallidal region. Acta Psychiatr Neurol Scand 1960;35:358-377.
12. Alberts WW, Feinstein B, Levin G, Wright EW Jr, Darland MG, Scott EL:Stereotaxic surgery for parkinsonism:Clinical results and stimulation thresholds. J Neurosurg 1965;23:174-183.
13. Laitinen LV, Bergenheim AT, Hariz MI:Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992;76:53-61
14. Lehman RM, Mezrich R, Sage J, Goldbe L:Peri- and postoperative magnetic resonance imaging localization of pallidotomy. Stereotact Funct Neurosurg 1994;62:61-70.
15. Iacono RP, Shima F, Lonser RR, Kuniyoshi S, Maeda G, Yamada S:The results, indications, and physiology of posteroventral pallidotomy for patients with Parkinson's disease. Neurosurgery 1995; 36:1118-1127.
16. Graybiel AM, Ragsdale CW Jr:Biochemical anatomy of the striatum:in Emson PC (ed):Chemical Neuroanatomy. New York, Raven Press, 1983. pp 427-504.
17. Penney JB, Young AB:Striatal inhomogeneities and basal ganglia function. Movement Disorders 1986;1:3-15.
18. Nauta WJH:Reciprocal links of the corpus striatum with the cerebral cortex and limbic system:A common substrate for movement and thought?; in Muller J (ed):Neurology and Psychiatry:A Meeting of Minds. Basel, Karger, 1989.
19. Parent A, Hazrati LN:Anatomical aspects of information processing in primate basal ganglia. Trends Neurosci 1993;16:111-116.
20. Mink JW, Thach WT:Basal ganglia intrinsic circuits and their role in behavior. Curr Biol 1993;3: 950-957.
21. DeLong MR:Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990; 13:281-285.
22. Alexander GE, Crutcher MD:Functional architecture of basal ganglia circuits:Neural substrates of parallel processing. Trends Neurosci 1990;13:266-271.
23. Alexander GE, Crutcher MD, DeLong MR:Basal ganglia-thalamocortical circuits:Parallel substrates for motor, oculomotor, 'perfrontar and 'limbic' functions. Prog Brain Res 1990;85:119-146.
24. Parent A:Extrinsic connections of the basal ganglia. Trends Neurosci 1990;13:254-258.
25. Parent A, Cote PY, Lavoie B:Chemical anatomy of primate basal ganglia. Prog Neurobiol 1995;46: 131-197.
26. Cools A, van den Bercken J, Horsteink M:The basal ganglia and the programming of behavior. Trends Neurosci 1981;4:124.
27. Oberg RGE, Divac I:Levels of motor planning:Cognition and the control of movement. Trends Neurosci 1981;4:122-124.
28. Hikosaka O, Sakamoto M, Usui S:Functional properties of monkey caudate neurons. III. Activities related to expectation of target and reward J Neurophysiol 1989;61:814-832.
29. Marsden CD:Movement disorders and the basal ganglia. Trends Neurosci 1986;9:512-515.
30. Lidsky TI, Manetto C, Schneider JS:A consideration of sensory factors involved in motor functions of the basal ganglia. Brain Res 1985;9:133-146.
31. Schwarz M, Block F, Topper R, et al:Abnormalities of somatosensory evoked potentials in the quinolinic acid model of Huntington's disease:Evidence that basal ganglia modulate sensory cortical input. Ann Neurol 1992;32:358-364.
32. Schneider JS, Diamond SG, Markham GH:Deficits in orofacial sensorimotor function in Parkinson's disease. Ann Neurol 1986;19:275-282.
33. Butter CM, Snyder DR:Alterations in aversive and aggressive behaviors following orbital frontal lesions in rhesus monkeys. Acta Neurobiol Exp (Warsz) 1972;32:525-565.
34. Majovski LV, Jacques S, Hartz G, Fogwell LA:Dopaminergic (DA) systems:Their role in pathological neurobehavioral symptoms. Neurosurgery 1981;9:751-757.
35. Afifi AK:Basal ganglia:Functional anatomy and physiology. Part 2. J Child Neurol 1994;9:352-361.
36. Alexander GE, DeLong MR, Strick PL:Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-381.
37. Albin RL, Young AB, Penney JB:The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-375.
38. Chevalier G, Deniau JM:Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci 1990;13:277-280.
39. Parent A, Bouchard C, Smith Y:The striatopallidal and striatonigral projections:Two distinct fiber systems in primate. Brain Res 1984;303:385-390.
40. Fisher RS, Buchwald NA, Hull CD, Levine MS:Neurons of origin of striatonigral axons in the cat:connectivity and Golgi markers of somatodendritic architecture. Brain Res 1986;397:173-180.
41. Smith Y, Parent A, Seguela P, Descarries L:Distribution of GABA-immunoreactive neurons in the basal ganglia of the squirrel monkey (Saimiri sciureus). J Comp Neurol 1987;259:50-64.
42. Parent A, Smith Y, Filion M, Dumas J:Distinct afferents to internal and external pallidal segments in the squirrel monkey Neurosci Lett 1989;96:140-144.
43. Reiner A, Anderson KD. The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons:Conclusions based on recent findings. Brain Res Brain Res Rev 1990; 15:251-265.
44. Graybiel AM, Liu FC, Dunnett SB:Cellular reaggregation in vivo:Modular patterns in intrastriatal grafts derived from fetal striatal primordia. Prog Brain Res 1990;82:401-405.
45. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990;250:1429-1432.
46. Filion M, Tremblay L, Bedard PJ:Abnormal influences of passive limb movement on the activity of globus pallidus neurons in parkinsonian monkeys. Brain Res 1991;444:165-176.
47. Filion M, Tremblay L:Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1995;547:142-151.
48. Crossman AR:Neural mechanisms in disorders of movement. Comp Biochem Physiol [A] 1989;93: 141-149.
49. Dogali M, Beric A, Sterio D, Eidelberg D, Fazzini E, Takikawa S, Samelson DR, Devinsky O, Kolodny EH:Anatomic and physiological considerations in pallidotomy for Parkinson's disease. Stereotact Funct Neurosurg 1994;62:53-60.
50. Ceballos-Baumann AO, Obeso JA, Vitek JL, Delong MR, Bakay R, Linazasoro G, Brooks DJ:Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease. Lancet 1994;344:814.
51. Sterio D, Beric A, Dogali M, Fazzini E, Alfaro G, Devinsky O:Neurophysiological properties of pallidal neurons in Parkinson's disease. Ann Neurol 1994;35:586-591.
52. Rascol O, Sabatini U, Chollet F, Celsis P, Montastruc JL, Marc-Vergnes JP, Rascol A:Supplementary and primary sensory motor area activity in Parkinson's disease:Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch Neurol 1992,49:144-148.
53. Jeakins IH, Fernandez W, Playford ED, Lees AJ, Frackowiak RS, Passingham RE, Brooks DJ:Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurol 1992;32:749-757.
54. Meyers R:The modification of alternating tremor, rigidity and festination by surgery of the basal ganglia. Res Publ Assoc Nerv Ment Dis 1942;21:602-665.
55. Browder J:Section of the fibers of the anterior limb of the internal capsule in parkinsonism. Am J Surg 1948;75:264.
56. Spiegal EA, Wycis HT:Pallido-thalamotomy in chorea. Arch Neurol Psychiatr 1950;64:495.
57. Guiot G, Brion S:Traitement des mouvements anormaux par la coagulation pallidale. Technique et résultats. Rev Neurol 1953;89:578-580.
58. Cooper IS, Bravo G:Chemopallidectomy and chemothalamectomy. J Neurosurg 1958;15:244-250.
59. Hassler R, Riechert T:Indikationen und Lokalisationsmethode der gezielten Hirnoperationen. Nervenarzt 1954;25:441-447.
60. Skinner JE, Lindsley DB:Reversible cryogenic blockade of neural function in the brain of unrestrained animals. Science 1968;161:595-597.
61. Wright BM:Nitrous-oxide-cooled neurosurgical cryoprobe. Lancet 1971;i:951-952.
62. Quigley MR, Loesch DV, Shib T, Marquardt M, Lupetin A, Maroon JC:Intracranial cryosurgery in a canine model:A pilot study. Surg Neurol 1992;38:101-105.
63. Cooper IS:Intracerebral injection of procaine into the globus pallidus in hyperkinetic disorders. Science 1954;119:417.
64. Umbach W, Ehrhardt KJ:Microelectrode recording in the basal ganglia during stereotaxic operations. Confin Neurol 1965;26:315-317.
65. Bertrand G, Jasper H, Wong A, Mathews G:Microelectrode recording during stereotactic surgery. Clin Neurosurg 1969;16:328-355.
66. Hutchison WD, Lozano AM, Davis KD, Saint-Cyr JA, Lang AE, Dostrovsky JO:Differential neuronal activity in segments of globus pallidus in Parkinson's disease patients. Neuroreport 1994;5: 1533-1537.
67. Lozano A, Hutchison W, Kiss Z, Tasker R, Davis K, Dostrovsky J:Methods for microelectrode-guided posteroventral pallidotomy. J Neurosurg 1996;84:194-202.
68. Kopyov OV, Jacques D, Duma C, Lieberman A, Rogers R, Copcutt B:One year's experience with microelectrode-guided posteroventral radiofrequency pallidotomy in Parkinson's disease patients. Am Acad Neurol 1996;Poster P02:107.
69. Jones MW, Tasker RR:The relationship of documented destruction of specific cell types to complications and effectiveness in thalamotomy for tremor in Parkinson's disease. Stereotact Funct Neurosurg 1990;54-55:207-211.
70. Laitinen LV:Ventroposterolateral pallidotomy. Sterotact Funct Neurosurg 1994;62:41-52.
71. Iacono RP, Lonser RR, Oh A, Yamada S:New pathophysiology of Parkinson's disease revealed by posteroventral pallidotomy. Neurol Res 1995;17:178-180.
72. Laitinen LV:Pallidotomy for Parkinson's disease. Stereotact Func Neurosurg 1995;6:105-112.
73. Sutton JP, Couldwell W, Lew MF, Mallory L, Grafton S, DeGiorgio C, Welsh M, Apuzzo ML, Ahmadi J, Waters CH:Ventroposterior medial pallidotomy in patients with advanced Parkinson's disease. Neurosurgery 1995;36:1112-1167.
74. Iacono RP, Lonser RR, Mandybur G, Morenski JD, Yamada S, Shima F:Stereotactic pallidotomy results for Parkinson's exceed those of fetal graft. Am Surg 1994;60:777-782.
75. Meyers R:Surgical experiments in the therapy of certain 'extrapyramidal' diseases:A current evaluation. Acta Psychiatr Neurol 1951;26:1-42.
76. Hassler R, Reichert T, Mundinger F, Umbach WJ, Ganglberger JA:Physiological observations in Stereotaxic operations in extrayramidal motor disturbances. Brain 1960;83:337-350.
77. Alberts WW, Feinstein B, Levin G, Wright EW Jr:Electrical stimulation of therapeutic targets in waking dyskinetic patients. Electroencephalogr Clin Neurophysiol 1966;20:559-566.
78. Schaltenbrand G, Spuler H, Wahren W, Rumler B:Electroanatomy of the thalamic ventro-oral nucleus based on stereotaxic stimulation in man. Z Neurol 1971;199:259-276.
79. Siegfried J:Therapeutical neurostimulation - indications reconsidered. Acta Neurochir Suppl (Wien) 1991;52:112-117.
80. Siegfried J, Comte P, Meier R:Intracerebral electrode implantation system:Technical note. J Neurosurg 1983;59:356-359.
81. Siegfried J, Rea G:Advances in neurostimulation devices; in Pluchina F, Broggi G (eds):Advanced Technology in Neurosurgery. Berlin, Springer, 1988, pp 199-207.
82. Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM, Hommel M, Perret JE, de Rougemont J:Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991;337:403-406.
83. Benabid AL, Pollak P, Gao D, Hoffmann D, Limousin P, Gay E, Payen I, Benazzouz A:Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg 1996;84:203-214.
84. Blond S, Siegfried J:Thalamic stimulation for the treatment of tremor and other movement disorders. Acta Neurochir Suppl (Wien) 1991;52:109-111.
85. Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J:Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 1987;50:344-346.
86. Siegfried J, Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum:A new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 1994;35:1126-1130.
87. Hosobuchi Y:Subcortical electrical stimulation for control of intractable pain in humans:Report of 122 cases (1970-1984). J Neurosurg 1986;64:543-553.
88. Young RE:Intracranial procedures for pain management; in Apuzzo MLJ (ed):Brain Surgery:Complication Avoidance and Management. New York, Churchill Livingstone, 1993, pp 1497-1508.
89. Olanow CW, Kordower JH, Freeman TB:Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 1996;19:102-109.
90. Brundin P, Duan WM, Sauer H:Functional effects of mesencephalic dopamine neurons and adrenal chromaffin cells grafted to the rodent striatum; in Dunnett SB, Bjorklund A (eds):Functional Neural Transplantation. New York, Raven Press, 1994, pp 9-46.
91. Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, Leenders KL, Sawle G, Rothwell JC, Marsden CD:Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990;247:574-577.
92. Freeman TB, Olanow CW, Hauser RA, Nauert GM, Smith DA, Brolongan CV, Sanberg PR, Holt DA, Kordower JH, Vingerhoets FJ:Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 1995;38:379-388.
93. Kopyov OV, Jacques DB, Lieberman A, Duma CM, Rogers RL:Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease. Cell Transplant 1996;5: 1-11
94. Thomas CL:Taber's Medical Dictionary. Philadelphia, Davis, 1973.
95. Testerman MR:Legal challenges to denials of insurance coverage for 'experimental' medical treatments. Mo Med 1992;89:222-225.